DUOT (40) GIBO (45) ZENA (54) EXFY (46) ⌘ Pro Terminal →

Exascale Labs Holdings Inc. (Class A) (XLAB) — RQD Stock Rating Cockpit

$3.15 -0.63% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $3.14

Exascale Labs Holdings Inc. (Class A) (XLAB) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $202.7M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $3.14 (-0.30%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.1% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-9.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for XLAB)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (37/100 Composite)

🔍 WHY XLAB SCORES 37/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+10/20 pts (27% of score)

FRED Regime × Technicals: 23% of 52W Range • RSI-14 at 51 (NEUTRAL RANGE)

▲ #2 Bullish Driver: Whale & Options Positioning+9/20 pts (24% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$0.97+142.3% Next Q

Q2 (-2Q)

Grade E$2.35+42.6% Next Q

Q3 (-1Q)

Grade E$3.35-6% Next Q

Current

Grade D-$3.15-8.1% Hist 90D α

Trajectory: E (29) → D- (37)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a XLAB Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While XLAB currently carries a cautious 37/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.06) and Max Pain ($3.31) forces dealer call-delta covering toward $11.73.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $XLAB• $4.8M Crowd Pool • Kalshi / Polymarket Composite

Contract: “XLAB Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”

YES 37%NO 63%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

5130 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

1 / 99-Pt Accounting

52-WEEK LASER RANGE23% OF RANGE

L: $1$3.15H: $11

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: D-RQD 7 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 12 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 18 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on XLAB

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (35)

-23.7% ROIC with 15.8% gross margin and -0.50% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (40)

Altman-Z 4.20 and Piotroski 1/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (37)

12/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like XLAB

✓Established market leader in Technology with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring XLAB)

✓Walkthrough of XLAB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

XLAB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -69.24%▼ DESCENDING CHANNEL

2026-10-30O $3.01H $3.15L $2.82C $3.15VOL 379.1K

RES: $4.45SUP: $0.12SMA50: $3.06SMA200: $8.03

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

XLAB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 XLAB Butterfly Map → + Track XLAB →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on XLAB today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for XLAB. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for XLAB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (XLAB)

Technology Rank #590 of 714 ⚔️ DUOT vs XLAB Full Matrix →

1. Head-to-Head Technology Peer Comparison (XLAB vs. DUOT, GIBO, ZENA, EXFY)

Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, Exascale Labs Holdings Inc. (Class A) (XLAB) ranks #590 by composite RQD confidence (37/100, grade D-) and #476 by equity capitalization ($202.7M). Within this direct 5-issuer industry benchmark cohort, XLAB leads on earnings valuation at N/A trailing P/E, while DUOT leads on capital efficiency and profitability with -15.9% ROIC and 29.2% gross margin. ZENA currently holds the highest overall quantitative score in the immediate peer group at 54/100 (D+) compared with XLAB at 37/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
XLAB ACTIVE Exascale Labs Holdings Inc. (Class A)	D-	37/100	—	15.8%	-23.7%	-0.63%	$202.7M	Benchmark Subject
DUOT Duos Technologies Group Inc.	D-	40/100	—	29.2%	-15.9%	+0.47%	$203.3M	/duot-vs-xlab →
GIBO GIBO Holdings Limited (Class A)	D	45/100	—	—	-35.0%	+2.42%	$192.2M	/gibo-vs-xlab →
ZENA ZenaTech Inc.	D+	54/100	—	—	—	-0.05%	$185.8M	/zena-vs-xlab →
EXFY Expensify Inc. (Class A)	D	46/100	—	50.3%	-20.4%	-2.41%	$221.6M	/exfy-vs-xlab →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0002109869

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Exascale Labs Holdings Inc. (Class A) (XLAB) reported GAAP revenue of $7.0M , GAAP net income of -$7.7M, operating cash flow of -$1.0M, and free cash flow of -$1.0M . On the balance sheet, XLAB closed FY2025 with $0 in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-06-30	$7.0M	-$7.7M	-$1.0M	-$1.0M	—	—

3. XLAB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is XLAB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Exascale Labs Holdings Inc. (Class A) (NASDAQ: XLAB) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $3.15 (-0.63% 1D, market cap $202.7M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 714 tracked Technology issuers, XLAB ranks #590 in composite RQD confidence.

How does XLAB compare to DUOT and GIBO in the Technology sector?

Within the Technology sector (Computer Software: Prepackaged Software), XLAB carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 15.8%, and ROIC of -23.7%. By comparison, DUOT (Duos Technologies Group Inc.) holds a D- grade (40/100 RQD, P/E N/A, ROIC -15.9%, cap $203.3M) and GIBO (GIBO Holdings Limited (Class A)) posts a D grade (45/100 RQD, P/E N/A, ROIC -35.0%, cap $192.2M). Among the 5-stock peer group, XLAB leads on earnings multiple (N/A) while DUOT leads on capital efficiency (-15.9% ROIC).

What are the biggest fundamental strengths and SEC risk factors for XLAB?

Per XLAB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0002109869), Exascale Labs Holdings Inc. (Class A) generated $7.0M in revenue, -$7.7M in net income, and -$1.0M in free cash flow against $0 in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is XLAB trading relative to its 50-day, 200-day, and 52-week technical levels?

XLAB last traded at $3.15 (-0.63% on volume of 1,251,708 shares), positioning the stock +2.94% above its 50-day simple moving average ($3.06) and -60.77% below its 200-day simple moving average ($8.03). Across its 52-week range of $0.78 to $11.17, XLAB sits at the 22.8% percentile with a 14-day RSI of 51.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.76 to $3.54).

XLAB Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell XLAB stock right now?

Exascale Labs Holdings Inc. (Class A) (XLAB) currently earns a Roarable Rating of D- (Sell — SELL) with 37/100 RQD Confidence. Stretched risk/reward at current multiples (-24% return on capital) under elevated 10-year interest-rate pressure.

What is XLAB's 12-month price target and RQD AI Jury consensus?

XLAB's 12-month base price target is $2.85 (range $2.22 to $11.73), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: XLAB RQD Cockpit XLAB 12M Forecast XLAB Earnings & Move XLAB Dividends & DRIP XLAB Insiders & 13F XLAB Whale Options XLAB Profit Sankey XLAB News & Why